Regarding immunohistochemistry (IHC) subtypes, there were 179 hormone receptor (HR)-positive/HER2-negative, 23 HR+/HER2+, 32 HR-/HER2-, and 12 HR-/HER2+ breast cancers, and 59 patients had a family history of breast cancers. The gene discussed is NR4A1; the disease is breast carcinoma.